Clinical trial
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP…
NCT00222092 · University of Ioannina, Other · Completed
Key facts
| NCT number | NCT00222092 |
|---|---|
| Title | Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers |
| Official title | Effect of Octreotide, Somatostatin, Pentoxyfilline or Placebo in the Prevention and the Course of Post-ERCP Pancreatitis and Study of Molecular Markers in Post-ERCP Pancreatitis |
| Lead sponsor | University of Ioannina, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Post-ERCP Acute Pancreatitis |
| Enrollment | 300 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 24, 2011 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: